Salivary gland tumours in Iceland 1986-2015: a nationwide epidemiological analysis over a 30-year time period.

To access publisher's full text version of this article click on the hyperlink below Salivary gland tumours (SGT) are a vast and heterogenous group of neoplasms. There is a relative lack of comprehensive nationwide epidemiological studies on the subject. The aim of this nationwide analysis was...

Full description

Bibliographic Details
Published in:APMIS
Main Authors: Aegisdottir, Anna Lilja, Tryggvason, Geir, Jonsdottir, Anna Margret, Jonasson, Jon Gunnlaugur
Other Authors: 1Faculty of Medicine, University of Iceland, Reykjavik, Iceland. 2Department of Otorhinolaryngology, The National University Hospital of Iceland, Reykjavik, Iceland. 3Department of Pathology, The National University Hospital of Iceland, Reykjavik, Iceland.
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 2020
Subjects:
Online Access:http://hdl.handle.net/2336/621593
https://doi.org/10.1111/apm.13090
Description
Summary:To access publisher's full text version of this article click on the hyperlink below Salivary gland tumours (SGT) are a vast and heterogenous group of neoplasms. There is a relative lack of comprehensive nationwide epidemiological studies on the subject. The aim of this nationwide analysis was to gain insight into epidemiological traits, such as site, incidence and histological subtypes of SGT in general. Patients diagnosed with a primary SGT between 1986 and 2015 were identified from The Icelandic Cancer Registry and registries from all pathology departments in Iceland. Information on age, sex, tumour location and histology was retrieved from pathology reports. A total of 687 patients were diagnosed with a SGT, 609 (89%) were benign and 78 (11%) malignant. 9% of parotid gland tumours, 22% of submandibular gland tumours and 26% of minor SGT were malignant. The most common malignant tumours were mucoepidermoid carcinoma, acinic cell carcinoma and adenoid cystic carcinoma. The incidence of benign SGT was 4.9 per 100 000 among men and 7.0 per 100 000 among women. The incidence of malignant tumours was 0.59 per 100 000 for men and 0.79 per 100 000 for women. The proportion of malignant SGT is lower than most often reported. Only 10% of parotid gland tumours, 20% of submandibular gland tumours and 25% of minor salivary gland tumours are malignant. Keywords: Salivary gland; epidemiology; histology; oncology; tumour.